The development and use of quality-of-life measures to evaluate health outcomes in Japan

PharmacoEconomics

Volumn 20, Issue SUPPL. 2, 2002, Pages 17-23

  Fukuhara, Shunichi ^a   Ikegami, Naoki ^b   Torrance, George W ^c,d,e   Nishimura, Shuzo ^a   Drummond, Michael ^f,g   Schubert, François ^h  

^a KYOTO UNIVERSITY   (Japan)

^b KEIO UNIVERSITY   (Japan)

^c MCMASTER UNIVERSITY   (Canada)

^d i3 Global   (Canada)

^e Health Utilities Incorporated   (Canada)

^f UNIVERSITY OF YORK   (United Kingdom)

^g Innovus Research UK   (United Kingdom)

^h INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; COST UTILITY ANALYSIS; ECONOMIC EVALUATION; EVALUATION; HEALTH CARE UTILIZATION; HEALTH ECONOMICS; JAPAN; MEASUREMENT; MEDICAL TECHNOLOGY; PRIORITY JOURNAL; QUALITY OF LIFE;

EID: 0036376509     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-200220002-00003     Document Type: Conference Paper

References (27)

1. Why has the use of health economic evaluation in Japan lagged behind that in other developed countries?
2. Information barriers to the implementation of economic evaluations in Japan
3. Utility approach to measuring health-related quality of life
4. Valuing health-related quality of life
5. The Health Utilities Index (HUI) system for assessing health-related quality of life in clinical studies
6. Deriving a preference-based single index from the UK SF-36 Health Survey
7. Outcome measurement in economic evaluation
8. Assigning values to intermediate health states for cost-utility analysis: Theory and practice
9. EuroQol: A new facility for the measurement of health-related quality of life
10. Health status in Japanese population: Results from Japanese EuroQol study
11. Estimating an EQ-SD population value set: The case of Japan
12. The MOS 36-item short form survey (SF-36). I. Conceptual framework and item selection
13. International Quality of Life Assessment (IQOLA) project
14. Translation, adaptation and validation of the SF-36 Health Survey for use in Japan
15. Psychometric and clinical tests of validity of the Japanese SF-36 health survey
16. Health-related quality of life among renal-transplant recipients in Japan
17. Review of research articles about 'quality of life' in Japan
18. A review of the use of health status measures in economic evaluation
19. The role of the EuroQoL instrument in QALY calculations
20. Using the SF-36 and the EuroQoL on an elderly population
21. Testing the validity of the EuroQoL and comparing it with the SF-36 health survey questionnaire
22. Application to multi-attribute utility theory to measure social preference for health states
23. An assessment of global health status in survivors of acute lymphoblastic leukaemia in childhood
24. Designing and conducting cost-utility analyses
25. Measuring the value of program outcomes: A review of multiattribute utility measures
26. Social preferences for health states: An empirical evaluation of three measurement techniques